Table 3.
Authors | Study Type | Type of Cells or Tissue | Study Design | Results |
---|---|---|---|---|
Vezdrevanis 2011 [57] |
In vivo | Prostatic cancer | Injected BoNT into prostate | Tumor size reduction |
Ulloa et al., 2015 [58] | In vivo | Glioblastoma cells | Cells with or without transfection by BoNT-C1 injected into mice striatum | By BoNT-C1 blocks the growth of Glioblastoma cells via blocking Syntaxin1 |
He et al., 2016 [59] |
In vivo | Mice with pancreatic tumor | Injected onaA or saline into tumor | Reduced tumor size; increased apoptosis |
Karsenty et al., 2009 [60] | In vitro | Prostate LNCaP and PC-3 cell lines | LNCaP and PC-3 cell lines were exposed to onaA | OnaA inhibited LNCasP cell proliferation; had no effect on PC-3 cell |
Nam et al., 2012 [61] | In vitro | Breast and colorectal cancer | PLC-γl-transformed cells were exposed to BoNT-A (difficile) | Caused apoptosis and mitotic inhibition |
Proietti et al., 2012 [62] | In vitro | Prostate LNCaP and PC-3 cell lines | Prostate cancer cell lines were exposed to incoA | Tumor cell growth slowed down probably due to toxin effect on SV2 receptors |
Bandala et al., 2013 [63] | In vitro | Breast T47D cancer cells | Breast T47D cancer cells were exposed to diverse dilutions of BoNT | BoNT via caspase 3, slow down the growth of T47d cells and caused apoptosis |
Bandala et al., 2015 [64] | In vitro | Breast cancer cell line | Added BoNT-A to breast cancer cell line | BoNT-A diminished SV2 protein on the surface of breast cancer cells |
Rust et al., 2016 [65] | In vitro | Human neuroblastoma cells | Added BoNT-C to human neuroblastoma cell culture | Apoptosis of neuroblastoma cells |
Huang et al., 1998 [66] |
Invitro | Insulin secreting HIT-T15 cells | Insulin secreting cells were transfected by BoNT-A | Marked reduction of insulin secretion- potential to treat insulinoma |
Hajighasemlou et al., 2015 [67] | In vitro | Her2 positive breast cancer cell line | Assessed the effect of BoNT-A on Her2 positive cells responsive to Herceptin | Herceptin efficacy significantly improved |
Cheng et al., 2013 [68] | In vitro and in vivo | Prostate cancer cell line in Mice |
LNCaP and PC3 cancer cells were exposed to 1 to 10 units of onaA | No effect on tumor growth in LNCaP and PC3 cancer cells |
Ansiaux et al., 2006 [69] | In vivo | Fibrosarcoma, hepatosarcoma | BoNT-A injected into the tumor | Increased oxygenation of the tumor and made it more susceptible to chemo and radiotherapy |
Coarfa et al., 2017 [70] | In vivo | Prostate of 250 nude mice Four human cancerous prostates |
Effect of onaA versus saline injection into cancer cells implanted into rodent’s prostate Assessed the effect of onaA versus saline injection in cancerous prostate before prostatectomy |
Increased apoptosis; slowed cancer progression Increased apoptosis in ona-A injected side of prostate |
OnaA: OnabotulinumtoxinA (Botox). IncoA: IncobotulinumtoxinA (Xeomin).